Liposomes are well-established nanocarriers for improving the therapeutic index of anticancer agents. A remarkable understanding in the pathophysiology of breast cancer progression has emerged with ...

The addition of vintafolide to pegylated liposomal doxorubicin extended PFS in patients with recurrent platinum-resistant ovarian cancer, according to study results. Perspective from Maurie Markman, ...

Female patients were eligible with histologically confirmed MBC with at least one measurable lesion, at least one prior chemotherapy for metastatic disease, Karnofsky performance status ⩾70%, age >18 ...

Ipsen (Euronext: IPN; ADR: IPSEY) and Servier announced today initial safety and efficacy data from Part 1 of the Phase II/III RESILIENT study of investigational liposomal irinotecan (ONIVYDE®) in ...

SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma, Inc. reported in the March issue of Anticancer Research* that its proprietary intravenous liposomal curcumin (LipoCurc™) concentrates very intensely ...

A research team led by the Medical University of Vienna, the HUN-REN Research Centre for Natural Sciences and the Eötvös Loránd University in Budapest has developed a groundbreaking new ...

The following organisations accepted the invitation to participate in this appraisal as consultees and commentators. They were invited to comment on the draft scope, assessment report and the ...

Ewing, NJ's Celator Pharmaceuticals has raised $40.6 million by issuing 4.6 million additional shares of the company's common stock for $9.50 a share. That included 600,000 shares issued because the ...

Size is one of the decisive characteristics of liposomes for advanced chemotherapy of tumors. Larger sized liposomes are effectively taken up by the reticuloendothelial system (RES) and cleared from ...